Once-daily tavapadon offers a new Parkinson’s treatment option, with symptom benefits supported by trials and important ...

Five takeaways on progress altering the Parkinson’s therapeutic landscape, from day two of The Michael J. Fox Foundation’s ...

Delaying the use of subcutaneous Parkinson’s disease treatments by one year increases annual medical costs by 59.1%, ...

Forbes contributors publish independent expert analyses and insights. Michael Harley is a leading automotive industry expert and analyst. This voice experience is generated by AI. Learn more. This ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...

Approximately 10 million people worldwide suffer from Parkinson's, a condition named after Dr. James Parkinson. Michael J.

The M. Maral Mouradian and Suhayl Dhib-Jalbut Family Endowed Legacy Professorship will be a faculty position at the future ...

Add Yahoo as a preferred source to see more of our stories on Google. Beans may hold the key to unlocking a treatment for Parkinson's disease, researchers say. That's what researchers at the ...

NEW YORK, March 24, 2026 -- Olatec Therapeutics, Inc. ("Olatec"), developing one of the most clinically advanced specific oral NLRP3 inhibitors, dapansutrile, today announced that two patients have ...

GRAND RAPIDS, Mich. (Dec. 10, 2025) — Van Andel Institute and Cure Parkinson’s have renewed a funding agreement to support the International Linked Clinical Trials Program, the world’s largest drug ...

Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the striatum may improve the efficacy of a first-line therapy for Parkinson's ...

Add Yahoo as a preferred source to see more of our stories on Google. Photo by Tommaso Boddi/WireImage/AFP via Getty Images Michael J. Fox continued turning a personal battle into a powerful push for ...